Fosrenol® (lanthanum carbonate) – First-time generic
August 14, 2017 – Natco Pharma announced the approval of its AB-rated generic to Shire’s Fosrenol (lanthanum carbonate) chewable tablets, to reduce serum phosphate in patients with end stage renal disease.
Download PDF
